Directors Shrhldg-Replacement

Finsbury Worldwide Pharm Tst PLC
20 December 1999

The issuer has advised that the following alteration should be made to the
Finsbury Worldwide Pharmaceutical Trust, Director's Shareholding announcement
released today at 07:58  under RNS No 7622C. 

Box 12 should read 216p and not 362p as previously shown.

The full corrected version is shown below.



                       DEALINGS BY DIRECTORS


1)  NAME OF COMPANY

FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC

2)  NAME OF DIRECTOR

MR SAMUEL ISALY

3)  Please state whether notification indicates that it is in respect of
    holding of the Director named in 2 above or holding of that person's
    spouse or children under the age of 18 or in respect of a non-beneficial
    interest

DIRECTOR NAMED IN 2 ABOVE

4)  Name of the registered holder(s) and, if more than one holder, the
    number of shares held by each of them. (If notified)

NOT NOTIFIED

5)  Please state whether notification relates to a person(s) connected
    with the Director named in 2 above and identify the connected person(s)

N/A

6)  Please state the nature of the transaction. For PEP transactions
    please indicate whether general/single co PEP and if discretionary/non
    discretionary

PURCHASE

7)  Number of shares/amount of
    stock acquired

50,000

8)   (0.12%)
    of issued Class

9)  Number of shares/amount
    of stock disposed

N/A

10)  (N/A  % )
   of issued Class

11) Class of security

25P ORDINARY

12) Price per share

216P

13) Date of transaction

14 DECEMBER 1999

14) Date company informed

17 DECEMBER 1999

15) Total holding following this notification

141,000 SHARES

16) Total percentage holding of issued class following this notification

0.35%

     IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE
                    COMPLETE THE FOLLOWING BOXES

17) Date of grant



18) Period during which or date on which exercisable



19) Total amount paid (if any) for grant of the option



20) Description of shares or debentures involved: class, number.



21) Exercise price (if fixed at time of grant) or indication that price
    is to be fixed at time of exercise



22) Total number of shares or debentures over which options held
    following this notification



23) Any additional information

   This announcement is an amendment to the one made on 17 December 1999 for Mr
Isaly.  The previous announcement quoted an execution price of 362p.  This
should have been US$3.62, which converts to 216p.  All other details remain the
same.

24) Name of contact and telephone number for queries

DAVID FALLON     
Rea Brothers Limited - Secretary
Tel. [phone]

25) Name and signature of authorised company official responsible for
    making this notification

    Date of Notification....17 DECEMBER 1999........................